Castiglioni; Emiliano

Patent Applications and Registrations

Patent applications and USPTO patent grants for Castiglioni; Emiliano.The latest application filed is for "spiro (piperidine-4,2'-pyrrolidine)-1-(3,5-trifluoromethylphenyl) methylcarboxamides as nk1 tachikynin receptor antagonists".

Company Profile

0.4.10

Castiglioni; Emiliano - Verona IT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Spiro (piperidine-4,2'-pyrrolidine)-1-(3,5-trifluoromethylphenyl) methylcarboxamides as NK1 tachikynin receptor antagonists Grant 8,633,214 - Alvaro , et al. January 21, 2	2014-01-21
Spiro (piperidine-4,2'-pyrrolidine)-1-(3,5-trifluoromethylphenyl) Methylcarboxamides As Nk1 Tachikynin Receptor Antagonists App 20130123250 - ALVARO; GIUSEPPE ; et al.	2013-05-16
Spiro (piperidine-4,2'-pyrrolidine)-1-(3,5-trifluoromethyl phenyl) methylcarboxamides as NK1 tachikynin receptor antagonists Grant 8,367,692 - Alvaro , et al. February 5, 2	2013-02-05
Heteroaryl derivatives of N-{[(1S,4S,6S)-3-(2-pyridinylcarbonyl)-3-azabicyclo[4.1.0]hept-4-yl]methy- l}-2-amine Grant 8,133,908 - Alvaro , et al. March 13, 2	2012-03-13
Condensed N-Heterocyclic Compounds and their Use as CRF Receptor Antagonists App 20110172255 - Andreotti; Daniele ; et al.	2011-07-14
Spiro (Piperidine-4,2'-Pyrrolidine)-1-(3,5-Trifluoromethyl Phenyl) Methylcarboxamides As NK1 Tachikynin Receptor Antagonists App 20110053922 - Alvaro; Giuseppe ; et al.	2011-03-03
Spiro Compounds Useful as Antagonists of the H1 Receptor App 20100311734 - Botta; Maurizio ; et al.	2010-12-09
Novel compounds App 20100190764 - Castiglioni; Emiliano ; et al.	2010-07-29
Novel Compounds App 20100168131 - Alvaro; Giuseppe ; et al.	2010-07-01
Novel Compounds App 20100144760 - ALVARO; Giuseppe ; et al.	2010-06-10
Heteroaryl-substituted pyrrolo'2,3-b1 pyridine derivatives as crf receptor antagonists App 20070066640 - Castiglioni; Emiliano ; et al.	2007-03-22
Condensed n-heterocyclic compounds and their use as crf receptor antagonists App 20070004708 - Andreotti; Daniele ; et al.	2007-01-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.